HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations-Reference-Cited by-同舟云学术

HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations

Published:2005-12 Issue:1 Volume:50 Page:14-26
ISSN:0165-0173
Container-title:Brain Research Reviews
language:en
Short-container-title:Brain Research Reviews

Author:

Pocernich Chava B.,Sultana Rukhsana,Mohmmad-Abdul Hafiz,Nath Avindra,Butterfield D. Allan

Publisher

Elsevier BV

Subject

Clinical Neurology,General Neuroscience

Reference171 articles.

1. A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders;Neurology,1998

2. Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum;Aksenov;Neurosci. Lett.,2001

3. Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects;Allard;AIDS,1998

4. The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C;Amtmann;Drugs Exp. Clin. Res.,1996

5. Memantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitis;Anderson;J. Neurosci.,2004

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lactoferrin, the Moonlighting Protein of Innate Immunity;International Journal of Molecular Sciences;2023-11-02

2. HIV-1 Tat-mediated microglial ferroptosis involves the miR-204–ACSL4 signaling axis;Redox Biology;2023-06

3. The Epigenetic Role of miR-124 in HIV-1 Tat- and Cocaine-Mediated Microglial Activation;International Journal of Molecular Sciences;2022-11-30

4. Nanomedicines encountering HIV dementia: A guiding star for neurotherapeutics;Journal of Drug Delivery Science and Technology;2022-05

5. HIV-associated neurotoxicity and cognitive decline: Therapeutic implications;Pharmacology & Therapeutics;2021-11